For: | Abdul-Hai A, Abdallah A, Malnick SD. Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease. World J Hepatol 2015; 7(12): 1679-1684 [PMID: PMC4483549 DOI: 10.4254/wjh.v7.i12.1679] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i12/1679.htm |
Number | Citing Articles |
1 |
A. V. Sazhin, A. I. Khusyainova, V. A. Petukhov. Surgical management of diabetes mellitus: future outlook. Endoskopicheskaya khirurgiya 2017; 23(1): 46 doi: 10.17116/endoskop201723146-55
|
2 |
Ruifang Li, Yurong Yao, Pengfei Gao, Shurui Bu. The Therapeutic Efficacy of Curcumin vs. Metformin in Modulating the Gut Microbiota in NAFLD Rats: A Comparative Study. Frontiers in Microbiology 2021; 11 doi: 10.3389/fmicb.2020.555293
|
3 |
Iris Pinheiro, Aurora Barberá, Imma Raurell, Federico Estrella, Marcel de Leeuw, Selin Bolca, Davide Gottardi, Nigel Horscroft, Sam Possemiers, María Teresa Salcedo, Joan Genescà, María Martell, Salvador Augustin. A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo. Biomedicines 2022; 10(5): 1191 doi: 10.3390/biomedicines10051191
|
4 |
Chyntia Olivia Maurine JASIRWAN, Cosmas Rinaldi Adithya LESMANA, Irsan HASAN, Andri Sanityosos SULAIMAN, Rino Alvani GANI. The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms. Bioscience of Microbiota, Food and Health 2019; 38(3): 81 doi: 10.12938/bmfh.18-032
|
5 |
Hessam Yaghmaei, Seyed Ali Nojoumi, Masood Soltanipur, Hossein Yarmohammadi, Seyed Mohsen Mirhosseini, Mahdi Rezaei, Mohammadreza Jalali Nadoushan, Seyed Davar Siadat. The role of gut microbiota in non-alcoholic fatty liver disease pathogenesis. Obesity Medicine 2024; 50: 100551 doi: 10.1016/j.obmed.2024.100551
|
6 |
Cathrin Sellmann, Christian Degen, Cheng Jun Jin, Anika Nier, Anna Janina Engstler, Dana Hasan Alkhatib, Jean-Pascal De Bandt, Ina Bergheim. Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis. Amino Acids 2017; 49(7): 1215 doi: 10.1007/s00726-017-2423-4
|
7 |
Chang‐Hoon Lee, Seung Ho Choi, Goh Eun Chung, Boram Park, Min‐Sun Kwak. Nonalcoholic fatty liver disease is associated with decreased lung function. Liver International 2018; 38(11): 2091 doi: 10.1111/liv.13860
|
8 |
Cathrin Sellmann, Cheng Jun Jin, Anna Janina Engstler, Jean-Pascal De Bandt, Ina Bergheim. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD). European Journal of Nutrition 2017; 56(8): 2519 doi: 10.1007/s00394-016-1287-9
|
9 |
Katherine J. P. Schwenger, Colin M. Bolzon, Carrie Li, Johane P. Allard. Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria. European Journal of Nutrition 2019; 58(5): 1771 doi: 10.1007/s00394-018-1844-5
|
10 |
Margit Wunderlich, Manuel Miller, Bärbel Ritter, Ronan Le Gleut, Hannah Marchi, Monir Majzoub-Altweck, Patrick J. Knerr, Jonathan D. Douros, Timo D. Müller, Markus Brielmeier. Experimental colonization with H. hepaticus, S. aureus and R. pneumotropicus does not influence the metabolic response to high-fat diet or incretin-analogues in wildtype SOPF mice. Molecular Metabolism 2024; 87: 101992 doi: 10.1016/j.molmet.2024.101992
|
11 |
Jonathan M. Hazlehurst, Conor Woods, Thomas Marjot, Jeremy F. Cobbold, Jeremy W. Tomlinson. Non-alcoholic fatty liver disease and diabetes. Metabolism 2016; 65(8): 1096 doi: 10.1016/j.metabol.2016.01.001
|
12 |
Yi Chia Wu, Philip M. Chuang, Rachel Pinotti, Ankita Nagirimadugu, Nelson Valentin, Amreen Dinani. The association of impaired lung function and nonalcoholic fatty liver disease: a systematic review. European Journal of Gastroenterology & Hepatology 2021; 33(5): 745 doi: 10.1097/MEG.0000000000001967
|
13 |
Michael Doulberis, Georgios Kotronis, Dimitra Gialamprinou, Jannis Kountouras, Panagiotis Katsinelos. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. Metabolism 2017; 71: 182 doi: 10.1016/j.metabol.2017.03.013
|
14 |
Ayana R. Kumar, Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, Lekshmi R. Nath, Daniela Calina, Javad Sharifi-Rad. Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advances. European Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-024-02072-3
|
15 |
Benedetta M. Motta, Christoph Grander, Martin Gögele, Luisa Foco, Vladimir Vukovic, Roberto Melotti, Christian Fuchsberger, Alessandro De Grandi, Chiara Cantaloni, Anne Picard, Deborah Mascalzoni, Alessandra Rossini, Cristian Pattaro, Herbert Tilg, Peter P. Pramstaller. Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-02130-z
|
16 |
腸管不全とシトルリン投与. The Japanese Journal of SURGICAL METABOLISM and NUTRITION 2019; 53(6): 301 doi: 10.11638/jssmn.53.6_301
|
17 |
Huanzhuo Mai, Xing Yang, Yulan Xie, Jie Zhou, Qing Wang, Yiru Wei, Yuecong Yang, Dongjia Lu, Li Ye, Ping Cui, Hao Liang, Jiegang Huang. The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease. Frontiers in Microbiology 2024; 14 doi: 10.3389/fmicb.2023.1257903
|
18 |
Stephen Malnick, Yaakov Maor. The Interplay between Alcoholic Liver Disease, Obesity, and the Metabolic Syndrome. Visceral Medicine 2020; 36(3): 198 doi: 10.1159/000507233
|
19 |
Claudia P. Oliveira, Priscila de Lima Sanches, Erlon Oliveira de Abreu-Silva, Aline Marcadenti. Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease. Journal of Diabetes Research 2016; 2016: 1 doi: 10.1155/2016/4597246
|
20 |
Fabiana Andréa Moura, Kívia Queiroz de Andrade, Orlando Roberto Pimentel de Araújo, Valéria Nunes-Souza, Juliana Célia de Farias Santos, Luiza Antas Rabelo, Marília Oliveira Fonseca Goulart, Karina Reyes-Gordillo. Colonic and Hepatic Modulation by Lipoic Acid and/or N‐Acetylcysteine Supplementation in Mild Ulcerative Colitis Induced by Dextran Sodium Sulfate in Rats. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/4047362
|
21 |
Haitao Shi, Lijuan Mao, Lianli Wang, Xiaojing Quan, Xiaoyu Xu, Yan Cheng, Shanshan Zhu, Fei Dai. Small intestinal bacterial overgrowth and orocecal transit time in patients of nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e535 doi: 10.1097/MEG.0000000000002157
|
22 |
Victor Hugo Dantas Guimarães, Barbhara Mota Marinho, Daisy Motta-Santos, Gabriela da Rocha Lemos Mendes, Sérgio Henrique Sousa Santos. Nutritional implications in the mechanistic link between the intestinal microbiome, renin-angiotensin system, and the development of obesity and metabolic syndrome. The Journal of Nutritional Biochemistry 2023; 113: 109252 doi: 10.1016/j.jnutbio.2022.109252
|
23 |
Qinwei Yu, Zhenzhou Jiang, Luyong Zhang. Bile acid regulation: A novel therapeutic strategy in non-alcoholic fatty liver disease. Pharmacology & Therapeutics 2018; 190: 81 doi: 10.1016/j.pharmthera.2018.04.005
|
24 |
Stephen D. H. Malnick, Pavel Alin, Marina Somin, Manuela G. Neuman. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different. International Journal of Molecular Sciences 2022; 23(24): 16226 doi: 10.3390/ijms232416226
|